Phase IIb Study of AST-3424 in Patients With AKR1C3-high Expressing Advanced Hepatocellular Carcinoma

计划入组 75 人 · 首次发布于 2025 年 12 月 30 日

Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)

计划入组 67 人 · 首次发布于 2020 年 3 月 19 日

Predictive Factors for CNS Metastases in Early Breast Cancer Using Liquid Biopsy (AKRA CŽS)

计划入组 22 人 · 首次发布于 2026 年 3 月 3 日

AKR1C3 inhibitors (cancer)

aKRAS G13D (Oblique Therapeutics)

AKR1C3 inhibitor(University of Pennsylvania)

ZOHAIB AKRAM

Australia

Nine-Marker Molecular Signature Identified as Driver of Lapatinib Resistance in HER2-Positive Breast Cancer